David Risinger
Stock Analyst at Leerink Partners
(5)
Main Sectors:
38 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceutica... | Upgrades: Outperform | 458 456 | 385.74 | 18.21% | 5 | Sep 25, 2025 | |
MTSR Metsera | Downgrades: Market Perform | 77 57 | 52.25 | 9.09% | 2 | Sep 24, 2025 | |
ROIV Roivant Sciences | Maintains: Outperform | 18 22 | 15.17 | 45.02% | 5 | Sep 18, 2025 | |
JNJ Johnson & Johnson | Downgrades: Market Perform | 169 153 | 179.71 | -14.86% | 4 | May 13, 2025 | |
REGN Regeneron Pharmaceut... | Upgrades: Outperform | 762 834 | 563.9 | 47.9% | 9 | Feb 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 206 | 220.68 | -6.65% | 7 | Nov 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 55 73 | 44.1 | 65.53% | 4 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 49 69 | 15.2 | 353.95% | 2 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 7.26 | 120.39% | 1 | Oct 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 44 | n/a | n/a | 2 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 106 153 | 33.98 | 350.26% | 2 | Sep 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 15 10 | 14.07 | -28.93% | 3 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 28 2 | 2.09 | -4.31% | 2 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 47 | 23.58 | 99.32% | 1 | Apr 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 267 318 | 272.98 | 16.49% | 4 | Oct 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 11 | 23.26 | -52.71% | 2 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 410 458 | 724.6 | -36.79% | 16 | May 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 42 | 73.75 | -43.05% | 3 | Mar 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 81 91 | 112.1 | -18.82% | 3 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 49 48 | 23.76 | 102.02% | 14 | Feb 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 88 117 | n/a | n/a | 12 | Dec 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 7 10 | n/a | n/a | 2 | Jun 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 35 37 | 10.22 | 262.04% | 2 | Feb 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 162 176 | 127 | 38.58% | 3 | Apr 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 16 | 9.52 | 68.07% | 1 | Mar 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 53 45 | 21.45 | 109.79% | 7 | Mar 5, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 5 7 | n/a | n/a | 8 | Mar 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 35 | 6.47 | 440.96% | 4 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 41 | 19.6 | 109.18% | 5 | Nov 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 167 174 | 143.52 | 21.24% | 9 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 51 | 35.04 | 45.55% | 1 | Jul 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 13 8 | 18.34 | -56.38% | 14 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 18 | n/a | n/a | 12 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 97 89 | 78.54 | 13.32% | 8 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 16 | 27.89 | -42.63% | 6 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 3 | 9.75 | -69.23% | 4 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 156 | n/a | n/a | 8 | Jan 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 35 | n/a | n/a | 5 | Aug 17, 2018 |